Literature DB >> 29872244

Hypercoagulable States and Thrombophilias: Risks Relating to Recurrent Venous Thromboembolism.

Marissa D Rybstein1, Maria T DeSancho1.   

Abstract

Inherited and acquired thrombophilias and hypercoagulable states, such as active cancer, estrogen-induced, autoimmune disorders, major surgery, hospitalization, and trauma, are well-known risk factors for venous thromboembolism (VTE). The effect of these on recurrent VTE is different for each specific risk factor. The major risk factors affecting VTE recurrence include the presence of active cancer and an unprovoked first VTE. In addition, the use of combined female hormones in a woman with a previous history of estrogen-related VTE is a major risk factor for VTE recurrence. The extent of influence of inherited thrombophilia on the risk of recurrence is controversial. Conversely, the presence of antiphospholipid antibodies, specifically triple positive carriers, appears to increase the risk of VTE recurrence. Understanding the rates of recurrent VTE in a patient and the individual risk of bleeding is important in determining the duration of anticoagulation therapy.

Entities:  

Keywords:  hypercoagulable; interventional radiology; recurrent; thrombophilia; venous thromboembolism

Year:  2018        PMID: 29872244      PMCID: PMC5986576          DOI: 10.1055/s-0038-1642037

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  34 in total

1.  Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Authors:  Willem M Lijfering; Saskia Middeldorp; Nic J G M Veeger; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Journal:  Circulation       Date:  2010-04-05       Impact factor: 29.690

2.  Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).

Authors:  M Bazzan; A Vaccarino; S Stella; S Sciascia; B Montaruli; M T Bertero; R Carignola; D Roccatello
Journal:  Lupus       Date:  2015-12-08       Impact factor: 2.911

3.  Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Authors:  Jeffrey I Weitz; Anthonie W A Lensing; Martin H Prins; Rupert Bauersachs; Jan Beyer-Westendorf; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Maria C S Freitas; Gerlind Holberg; Ajay K Kakkar; Lloyd Haskell; Bonno van Bellen; Akos F Pap; Scott D Berkowitz; Peter Verhamme; Philip S Wells; Paolo Prandoni
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

4.  Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms.

Authors:  Jean-Christophe Ianotto; Marie-Anne Couturier; Hubert Galinat; Dominique Mottier; Christian Berthou; Gaëlle Guillerm; Eric Lippert; Aurélien Delluc
Journal:  Int J Hematol       Date:  2017-06-16       Impact factor: 2.490

Review 5.  Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence.

Authors:  Gabriela Medina; Eduardo Briones-García; María Pilar Cruz-Domínguez; Oscar I Flórez-Durante; Luis J Jara
Journal:  Autoimmun Rev       Date:  2017-02-13       Impact factor: 9.754

6.  Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital.

Authors:  A J Kwon; M Roshal; M T DeSancho
Journal:  J Thromb Haemost       Date:  2016-03-23       Impact factor: 5.824

Review 7.  International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  D Farge; P Debourdeau; M Beckers; C Baglin; R M Bauersachs; B Brenner; D Brilhante; A Falanga; G T Gerotzafias; N Haim; A K Kakkar; A A Khorana; R Lecumberri; M Mandala; M Marty; M Monreal; S A Mousa; S Noble; I Pabinger; P Prandoni; M H Prins; M H Qari; M B Streiff; K Syrigos; H Bounameaux; H R Büller
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

Review 8.  The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.

Authors:  Antonio Marchiori; Laura Mosena; Martin H Prins; Paolo Prandoni
Journal:  Haematologica       Date:  2007-08       Impact factor: 9.941

9.  The incidence and risk factors of recurrent venous thromboembolism during pregnancy.

Authors:  Päivi J Galambosi; Veli-Matti Ulander; Risto J Kaaja
Journal:  Thromb Res       Date:  2014-05-02       Impact factor: 3.944

10.  Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2017-01       Impact factor: 10.047

View more
  8 in total

Review 1.  Role of Interventional Radiologist in the Management of Acute Pulmonary Embolism.

Authors:  William Bremer; Charles E Ray; Ketan Y Shah
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

2.  Efficacy and safety profiles of mechanical and pharmacological thromboprophylaxis.

Authors:  Mario Ganau; Gianfranco K I Ligarotti; Marco Meloni; Salvatore Chibbaro
Journal:  Ann Transl Med       Date:  2019-09

3.  Pulmonary embolism originating from germ cell tumor causes severe left ventricular dysfunction in a healthy young adult with full recovery: a case report.

Authors:  Khaled Elenizi; Rasha Alharthi; Michel Galinier
Journal:  BMC Cardiovasc Disord       Date:  2021-05-26       Impact factor: 2.298

4.  Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy.

Authors:  Jing-Chun Song; Li-Kun Yang; Wei Zhao; Feng Zhu; Gang Wang; Yao-Peng Chen; Wei-Qin Li
Journal:  Mil Med Res       Date:  2021-04-12

5.  The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study.

Authors:  Walid Saliba; Devy Zisman; Tal Gazitt; Jacob Pesachov; Idit Lavi; Muna Elias; Amir Haddad; Ilan Feldhamer; Arnon Dov Cohen
Journal:  Arthritis Res Ther       Date:  2022-01-07       Impact factor: 5.156

6.  Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens.

Authors:  Peyton Cramer; Cheryl Mensah; Maria DeSancho; Anuj Malhotra; Ronald Winokur; Andrew Kesselman
Journal:  World J Radiol       Date:  2021-12-28

7.  Ileocolic Thrombophlebitis and Lymphadenitis Mimicking Acute Appendicitis as a Late Manifestation in a COVID-19 Patient: A Case Report.

Authors:  Meng-Yi Chou; Che-Yuan Cheng; Shing-Jhong Long; Kai-Wen Yang; Yung Hsu
Journal:  Cureus       Date:  2022-09-11

8.  Trends of Ordering Hypercoagulability Work-Up at an Academic Medical Center.

Authors:  Marjan Alidoost; Gabriella A Conte; Varsha Gupta; Swapnil Patel; Ishan Patel; Mohammed Shariff; Shreya Gor; Michael J Levitt; Arif Asif; Mohammad A Hossain
Journal:  J Blood Med       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.